Home > Cardiology > HOPE 4 trial: Community-based intervention successful in reducing CV risk in hypertensive patients

HOPE 4 trial: Community-based intervention successful in reducing CV risk in hypertensive patients

Conference
ESC 2019
Trial
HOPE 4
A reduction of more than 75% in cardiovascular risk has been achieved with a community-based intervention aimed at patients with new or poorly controlled hypertension in Colombia and Malaysia. Key to the success of this care model was addressing multiple barriers to implementation by integrating efforts by the patient, family, or friends and their primary care physician, being led by non-physician health workers. Most of the burden of hypertension can be found in low- and middle-income countries, which prompted researchers of the HOPE 4 trial to find an effective method to safely and substantially reduce individual cardiovascular risk in patients [1]. The health outcomes prevention and evaluation 4 (Hope 4) is a community-based cluster randomised controlled trial including 1,371 patients  50 years with new or poorly controlled hypertension from 30 communities in Colombia and Malaysia. Of those, 16 communities (n=727) were randomised to usual care (control...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on